Lipid Apheresis to Manage Severe Hypertriglyceridemia during Induction Therapy in a Child with Acute Lymphoblastic Leukemia

References

• Steinherz PG. Transient, severe hyperlipidemia in patients with acute lymphoblastic leukemia treated with prednisone and asparaginase. Cancer. 1994;74(12):3234–3239. doi:10.1002/1097-0142(19941215)74:12 < 3234::aid-cncr2820741224 > 3.0.co;2-1.
   PubMed Web of Science ®Google Scholar
• Finch ER, Smith CA, Yang W, et al. Asparaginase formulation impacts hypertriglyceridemia during therapy for acute lymphoblastic leukemia. Pediatr Blood Cancer. 2020;67(1):e28040. doi:10.1002/pbc.28040.
   PubMed Web of Science ®Google Scholar
• Hinson A, Newbern D, Linardic CM. Asparaginase-induced hypertriglyceridemia presenting as pseudohyponatremia during leukemia treatment. Case Rep Pediatr. 2014;2014:1–5. doi:10.1155/2014/635740.
   Google Scholar
• Parsons SK, Skapek SX, Neufeld EJ, et al. Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia. Blood. 1997;89(6):1886–1895. doi:10.1182/blood.V89.6.1886.
   PubMed Web of Science ®Google Scholar
• Hoogerbrugge N, Jansen H, Hoogerbrugge PM. Transient hyperlipidemia during treatment of ALL with L-asparaginase is related to decreased lipoprotein lipase activity. Leukemia. 1997;11(8):1377–1379. doi:10.1038/sj.leu.2400703.
   PubMed Web of Science ®Google Scholar
• Bhojwani D, Darbandi R, Pei D, et al. Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia. Eur J Cancer. 2014;50(15):2685–2694. doi:10.1016/j.ejca.2014.06.023.
   PubMed Web of Science ®Google Scholar
• Cohen H, Bielorai B, Harats D, et al. Conservative treatment of L-asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2010;54:703–706. doi:10.1002/pbc.22305.
   PubMed Web of Science ®Google Scholar
• Tong WH, Pieters R, Groot-Kruseman HA, de, et al. The toxicity of very prolonged courses of PEGasparaginase or Erwinia asparaginase in relation to asparaginase activity, with a special focus on dyslipidemia. Haematologica. 2014;99(11):1716–1721. doi:10.3324/haematol.2014.109413.
   PubMed Web of Science ®Google Scholar
• Cremer P, Lakomek M, Beck W, Prindull G. The effect of L-asparaginase on lipid metabolism during induction chemotherapy of childhood lymphoblastic leukaemia. Eur J Pediatr. 1988;147(1):64–67. doi:10.1007/BF00442614.
   PubMed Web of Science ®Google Scholar
• Dietel V, Bührdel P, Hirsch W, Körholz D, Kiess W. Cerebral sinus occlusion in a boy presenting with asparaginase-induced hypertriglyceridemia. Klin Padiatr. 2007;219(2):95–96. doi:10.1055/s-2007-921455.
   PubMed Web of Science ®Google Scholar
• Athanassiadou F, Kourti M, Papageorgiou T, Stamou M, Makedou A, Boufidou A. Severe hyperlipidemia in a child with acute lymphoblastic leukemia treated with L-asparaginase and prednisone. Pediatr Int. 2004;46(6):743–744. doi:10.1111/j.1442-200x.2004.01991.x.
   PubMed Web of Science ®Google Scholar
• Kropshofer G, Wehl G, Högler W, Meister B, Heitger A, Nussbaumer W. Plasmapheresis as treatment for transient iatrogenic severe hyperlipidemia in a child with leukemia. Med Pediatr Oncol. 2003;41(2):177–177. doi:10.1002/mpo.10067.
   PubMedGoogle Scholar
• Solano-Páez P, Villegas JA, Colomer I, Gutierrez MD, Fernandez-Teijeiro A. L-Asparaginase and steroids-associated hypertriglyceridemia successfully treated with plasmapheresis in a child with acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2011;33:e122–4. doi:10.1097/MPH.0b013e3181faf7a1.
   PubMed Web of Science ®Google Scholar
• Ridola V, Buonuomo PS, Maurizi P, et al. Severe acute hypertriglyceridemia during acute lymphoblastic leukemia induction successfully treated with plasmapheresis. Pediatr Blood Cancer. 2008;50(2):378–380. doi:10.1002/pbc.20986.
   PubMed Web of Science ®Google Scholar
• Zawitkowska J, Lejman M, Zaucha-Prażmo A, Sekuła N, Greczkowska-Chmiel T, Drabko K. Severe drug-induced hypertriglyceridemia treated with plasmapheresis in children with acute lymphoblastic leukemia. Transfus Apher Sci. 2019;58(5):634–637. doi:10.1016/j.transci.2019.08.025.
   PubMed Web of Science ®Google Scholar
• Morand A, Barlogis V, Rouby F, Reynaud R, Marrec C, Michel G. Hypertriglycéridémie majeure, découverte sur une pseudohyponatrémie, induite par la l-asparaginase dans le cadre du traitement d’une leucémie aiguë lymphoblastique B pédiatrique. Therapie. 2016; S0040–5957(16)30051-8. doi:10.2515/therapie/2015051.
   PubMedGoogle Scholar
• Persson L, Harila-Saari A, Hed Myrberg I, Heyman M, Nilsson A, Ranta S. Hypertriglyceridemia during asparaginase treatment in children with acute lymphoblastic leukemia correlates with antithrombin activity in adolescents. Pediatr Blood Cancer. 2017;64(10):e26559. doi:10.1002/pbc.26559.
   Web of Science ®Google Scholar
• Berglund L, Brunzell JD, Goldberg AC, et al. Evaluation and treatment of hypertriglyceridemia: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(9):2969–2989. doi:10.1210/jc.2011-3213.
   PubMed Web of Science ®Google Scholar
• Hijiya N, van der Sluis IM. Asparaginase-associated toxicity in children with acute lymphoblastic leukemia. Leuk Lymphoma. 2016;57(4):748–757. doi:10.3109/10428194.2015.1101098.
   PubMed Web of Science ®Google Scholar
• Scherer J, Singh VP, Pitchumoni CS, Yadav D. Issues in hypertriglyceridemic pancreatitis: an update. J Clin Gastroenterol. 2014;48(3):195–203. doi:10.1097/01.mcg.0000436438.60145.5a.
   PubMed Web of Science ®Google Scholar
• Jain D, Zimmerschied J. Heparin and insulin for hypertriglyceridemia-induced pancreatitis: case report. ScientificWorldJournal. 2009;9:1230–1232. doi:10.1100/tsw.2009.142.
   PubMedGoogle Scholar
• Witztum JL, Gaudet D, Freedman SD, et al. Volanesorsen and triglyceride levels in familial chylomicronemia syndrome. N Engl J Med. 2019;381(6):531–542. doi:10.1056/NEJMoa1715944.
   PubMed Web of Science ®Google Scholar
• Tong WH, Pieters R, van der Sluis IM. Successful management of extreme hypertriglyceridemia in a child with acute lymphoblastic leukemia by temporarily omitting dexamethasone while continuing asparaginase. Pediatr Blood Cancer. 2012;58(2):317–318. doi:10.1002/pbc.23266.
   PubMed Web of Science ®Google Scholar